Key result
Higher baseline NT-proBNP (HR 2.11; 95% CI 1.75-2.55) and high-sensitivity troponin T (HR 1.42; 95% CI 1.20-1.68) were associated with incident atrial fibrillation in chronic kidney disease.
Why the study?
The study tested associations of cardiac biomarkers of myocardial stretch, injury, inflammation, and fibrosis with the risk of incident AF in chronic kidney disease patients.
Are higher baseline levels of cardiac biomarkers associated with an increased risk of incident atrial fibrillation in patients with chronic kidney disease?
Cohort (n=3,053)
Yes
Are higher baseline levels of cardiac biomarkers associated with an increased risk of incident atrial fibrillation in patients with chronic kidney disease?
Hazard Ratio: 2.11 (95% CI 1.75–2.55)
Elevated baseline levels of NT-proBNP and high-sensitivity troponin T are strongly associated with an increased risk of incident atrial fibrillation in patients with chronic kidney disease.
Authors
No takes yet. Share an insight, caveat, or question.
May aid AF risk stratification in CKD; leaves open whether biomarkers improve prediction or guide interventions.
Lamprea‐Montealegre et al. (2019) conducted a cohort in chronic kidney disease (n=3,053). Higher baseline cardiac biomarkers (NT-proBNP and high-sensitivity troponin T) was evaluated on Incident atrial fibrillation (hospitalization for AF) (HR 2.11, 95% CI 1.75, 2.55). Higher baseline NT-proBNP (HR 2.11; 95% CI 1.75-2.55) and high-sensitivity troponin T (HR 1.42; 95% CI 1.20-1.68) were associated with incident atrial fibrillation in chronic kidney disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: